(AP Photo/Virginia Mayo)

Up­dat­ed: Study iden­ti­fies Covid-19 pa­tients with mu­ta­tions in­di­cat­ing remde­sivir re­sis­tance

As the bi­va­lent boost­er sea­son kicks off in earnest, a new study pub­lished yes­ter­day from NYU re­searchers iden­ti­fies two cas­es of mu­tat­ed coro­n­avirus re­sis­tant to Gilead’s remde­sivir in im­muno­com­pro­mised in­di­vid­u­als.

The two pa­tients in their 50s and 60s had both un­der­gone kid­ney trans­plants (and were both vac­ci­nat­ed pri­or to those trans­plants), with one ex­pe­ri­enc­ing Covid for sev­er­al months while re­ceiv­ing rit­ux­imab and ben­damus­tine for lym­phoma.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.